GENCEBOK

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Spain.

Active ingredients

The drug GENCEBOK contains one active pharmaceutical ingredient (API):

1	Caffeine UNII U26EO4675Q - CAFFEINE CITRATE
	Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.
	Read more about Caffeine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GENCEBOK Solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06BC01	Caffeine	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BC Xanthine derivatives
Discover more medicines within N06BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1826175
ES	Centro de información online de medicamentos de la AEMPS	1201465001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	086864
FR	Base de données publique des médicaments	63865537
IT	Agenzia del Farmaco	048989014
LT	Valstybinė vaistų kontrolės tarnyba	1091009
NL	Z-Index G-Standaard, PRK	207012
PL	Rejestru Produktów Leczniczych	100440256